The Diagnostic Criteria 2020 for Triglyceride Deposit Cardiomyovasculopathy.

Adipose triglyceride lipase BMIPP Diagnostic criteria Rare and intractable diseases Tricaprin Triglyceride deposit cardiomyovasculopathy

Journal

Annals of nuclear cardiology
ISSN: 2424-1741
Titre abrégé: Ann Nucl Cardiol
Pays: Japan
ID NLM: 101747118

Informations de publication

Date de publication:
2020
Historique:
received: 13 07 2020
revised: 22 07 2020
accepted: 22 07 2020
medline: 1 1 2020
pubmed: 1 1 2020
entrez: 1 5 2023
Statut: ppublish

Résumé

Triglyceride deposit cardiomyovasculopathy (TGCV) is a newly identified disease that was discovered in individuals who required cardiac transplantation in Japan in 2008. Defective intracellular lipolysis causes triglyceride (TG) accumulation in the myocardium and coronary artery vascular smooth muscle cells, which results in severe heart failure and coronary artery disease with poor prognosis. A known cause of TGCV is a genetic deficiency of adipose triglyceride lipase (ATGL), a rate-limiting enzyme in the intracellular hydrolysis of TG. TGCV is classified into primary TGCV with ATGL mutations and idiopathic TGCV without ATGL mutations. Since its discovery, the Japan TGCV Study Group has attempted to elucidate its pathophysiology, develop diagnostic procedures, and specific treatment. Myocardial scintigraphy with iodine-123-

Identifiants

DOI: 10.17996/anc.20-00131 PMID: 37123492 PMC: PMC10133930
pubmed: 37123492
doi: 10.17996/anc.20-00131
pmc: PMC10133930
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

99-104

Informations de copyright

© The Japanese Society of Nuclear Cardiology 2020.

Déclaration de conflit d'intérêts

KH received grants from Nihon Medi-Physics Co. Ltd. KN received grants from Nihon Medi-Physics Co. Ltd. HY received honoraria for speaking activities from Bayer, Kowa, and Takeda Co. Ltd.

Références

Diabetes Care. 2019 May;42(5):983-986
pubmed: 30862655
Cardiovasc Drugs Ther. 2008 Apr;22(2):97-106
pubmed: 18253821
Arch Dermatol. 1974 Aug;110(2):261-6
pubmed: 4277517
Am J Med. 1954 Apr;16(4):504-15
pubmed: 13148192
Nat Genet. 2007 Jan;39(1):28-30
pubmed: 17187067
Br Med J. 1975 Mar 8;1(5957):553-5
pubmed: 1139147
Biochem Biophys Res Commun. 2018 Jan 1;495(1):646-651
pubmed: 29146190
N Engl J Med. 2008 Nov 27;359(22):2396-8
pubmed: 19038890
Orphanet J Rare Dis. 2019 Jun 11;14(1):134
pubmed: 31186072
J Nucl Med. 1996 Nov;37(11):1836-40
pubmed: 8917188
Pathol Int. 2014 Jul;64(7):325-35
pubmed: 25047503
Eur Heart J. 2015 Mar 1;36(9):580
pubmed: 25336228
J Oleo Sci. 2018 Aug 1;67(8):983-989
pubmed: 30012901
Acta Med Scand. 1953;145(6):419-23
pubmed: 13079655
JAMA Netw Open. 2020 Aug 3;3(8):e2012583
pubmed: 32766797
Orphanet J Rare Dis. 2013 Dec 21;8:197
pubmed: 24360150
Int J Card Imaging. 1999 Feb;15(1):11-20
pubmed: 10453398
J Clin Endocrinol Metab. 2008 Jul;93(7):2877-84
pubmed: 18445677
Eur J Nucl Med. 1986;12 Suppl:S39-44
pubmed: 3490376
Eur J Pediatr. 2007 Oct;166(10):1009-16
pubmed: 17206455
Biochem Biophys Res Commun. 2014 Jan 10;443(2):574-9
pubmed: 24332944
J Atheroscler Thromb. 2009 Oct;16(5):702-5
pubmed: 19729869

Auteurs

Kunihisa Kobayashi (K)

Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.

Yasuhiko Sakata (Y)

Department of Cardiovascular Medicine, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, Japan.

Hideyuki Miyauchi (H)

Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.

Yoshihiko Ikeda (Y)

Department of Pathology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Yasuyuki Nagasawa (Y)

Department of Internal Medicine, Division of Kidney and Dialysis, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.

Kenichi Nakajima (K)

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Kazunori Shimada (K)

Department of Functional Imaging and Artificial Intelligence, Kanazawa University, Ishikawa, Japan.

Junji Kozawa (J)

Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Osaka, Japan.

Hiroyuki Hao (H)

Division of Human Pathology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan.

Tetsuya Amano (T)

Department of Cardiology, Aichi Medical University, Aichi, Japan.

Hiroshi Yoshida (H)

Department of Laboratory Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan.

Tohru Inaba (T)

Department of Infection Control and Laboratory Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Chikako Hashimoto (C)

Laboratory of Cardiovascular Disease, Novel, Non-invasive, and Nutritional Therapeutics (CNT) and Triglyceride Research Center (TGRC), Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.

Ken-Ichi Hirano (KI)

Laboratory of Cardiovascular Disease, Novel, Non-invasive, and Nutritional Therapeutics (CNT) and Triglyceride Research Center (TGRC), Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.

Classifications MeSH